J.M. Le Moullec et al., “The complete sequence of human preprocalcitonin,” FEBS 1198, vol. 167, No. 1, Feb. 1984, pp. 93-97. |
J. Michael Conlon et al., “Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma,” Biochem, vol. 256, 1988, pp. 245-250. |
Pascale P. Ghillani et al., “Identification and Measurement of Calcitonin Precursors in Serum of Patients with Malignant Diseases,” Cancer Research, vol. 49, Dec. 1, 1989, pp. 6845-6851. |
Pascale Ghillani et al., “Monoclonal Antipeptide Antipeptide Antibodies As Tools To Dissect Closely Related Gene Products,” The Journal of Immunology, vol. 141, No. 9, Nov. 1, 1988, pp. 3156-3163. |
Michael Rehli et al., “Molecular Cloning and Expression of Mouse Procalcitonin,” Biochemical and Biophysical Research Communications, vol. 226, 1996, pp. 420-425. |
Dr. Sebastian Messerschmid, “Erzeugung von polyklonalen Antikörpern in Nicht-Säugern,” BIOforum, Nov. 1996, pp. 500-502. |
Antibodies—A Laboratory manual—1988. |
Monoklonale Antikörper. |
James W. Larrick et al., “Recombinant antibodies,” Review, vol. 2, Oct. 1991, pp. 172-189. |
Kazuaki Kitano et al., “Production of human monoclonal antibodies by heterohybridomas,” Appl Microbiol Biotechnol, vol. 24, 1986, pp. 282-286. |
Keith M. Thompson et al., “The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner,” Journal of Immunological Methods, vol. 94, 1996, pp. 7-12. |
Rainer Fischer et al., “Molecular Farming of REcombinant Antibodies in Plants,” Biol. Chem., vol. 380, Jul./Aug. 1999, pp. 825-839. |
Andrew Hiatt et al., “Assembly of Antibodies and Mutagenized Variants in Transgenic Plants and Plant Cell Cultures,” Genetic Engineering, vol. 14, 1992, pp. 49-64. |
R.C. Boguslaski et al., “Homogeneous Immunoassays,” Applied Biochemistry and Biotechnology, vol. 7, 1982, pp. 401-414. |
Edwin F. Ullman et al., “Luminescent oxygen channeling immunoassay: Measurement of particle binding kinetics by chemiluminescence,” Proc. Natl. Acad. Sci, USA, vol. 91, Jun. 1994, pp. 5426-5430. |
Edwin F. Ullman et al., “Luminescent oxygen channeling assay (LOCI™): sensitive, broadly applicable homogeneous immunoassay method,” Clinical Chemistry, vol. 42, No. 9, 1996, pp. 1518-1526. |
M. Philip Bailey et al., “On the use of fluorescent labels in immunoassay,” Journal of Pharmaceutical & Biomedical Analysis, vol. 5, No. 7, 1987, pp. 649-658. |
Sidney Udenfriend et al., “Scintillation proximity radioimmunoassay utilizing 125I-labeled ligands,” Proc. Natl. Acad. Sci, USA, vol. 82, Dec. 1985, pp. 8672-8676. |
Gérard Mathis, “Rare Earth Cryptates and Homogeneous Fluoroimmunoassays with Human Sera,” Clin. Chem, vol. 39, No. 9, 1993, pp. 1953-1959. |
Dialog (R) File 351: English Abstract of EP 1 026 506 A1. |
Dialog (R) File 351: English Abstract of EP 0 997 735 A2. |
Eric S. Nylen, MD, et al. , Mortality Is Increased by Procalcitonin and Decreased by an Antiserum Reactive to Procalcitonin in Experimental Sepsis, Crit Care Med 1998, vol. 26, No. 6, pp. 1001-1006. |
Michael Rehli, et al., “Molecular Cloning and Expression of Mouse Procalcitonin,” Biochemical and Biophysical Research Communications 226, Article No. 1371, pp. 420-425 (1996). |
Moullec et al., “The Complete Sequence of Human Preprocalcitonin,” Elsevier Science Publishers B.V., 1984 Federation of European Biochemical Societies, vol. 167, No. 1, Feb. 13, 1984, pp. 93-97. |
Xiao-Quing Liu, et al., “A Novel Method for Increasing Production of Mature Proteins in the Periplasm of Escherichia coli,” Protein Science (1999), vol. 8 No. 10, Oct. 1999, Cambridge University Press, The Protein Society, pp. 2085-2089. |
W. Karzai, et al., “Procalcitonin—A New Indicator of the Systemic Response to severe Infections,” Infection, 6, A Journal of Infectious Disease—Clinical Study and Treatmentvol. 25, Nov./Dec. 1997, pp. 329-334. |
S. Wrenger, et al., Amino-terminal Truncation of Procalcitonin, a Marker for Systemic Bacterial Infections, by Dipeptidyl Peptidase IV (DP IV), 2000 Federation of European Biochemical Societies Letters 466, No. 1, (2000), pp. 155-159. |